Pagine orfane

Le pagine indicate di seguito sono prive di collegamenti provenienti da altre pagine di WikiToLearn - collaborative textbooks e non sono incluse in alcuna pagina del sito.

Vengono mostrati sotto 50 risultati dal 1 al 50.

Vedi (precedenti 50 | successivi 50) (20 | 50 | 100 | 250 | 500).

  1. (55, 56). Disrupting the ASIC1a gene enhanced the severity from the seizure
  2. (55, 56). Disrupting the ASIC1a gene enhanced the severity in the seizure
  3. (55, 56). Disrupting the ASIC1a gene enhanced the severity of the seizure
  4. (55, 56). Disrupting the ASIC1a gene enhanced the severity of your seizure
  5. (55, 56). Disrupting the ASIC1a gene enhanced the severity with the seizure
  6. (Invitrogen (Cat No: A-6455)) at four . Right after various washes, the sections had been
  7. (Lamp-1) or Rab7- constructive late endosomal and lysosomal (LEL) compartments
  8. ), namely HPCAL1, HPCAL4, NCALD, ARRB1, PDE6D, and STK16. We in comparison
  9. , Bar graph represents the mean SEM of the percentage of POMC
  10. , response summarization had tiny impact on model functionality, warranting closer investigation
  11. -50 (ERM50). The PDZ motifs of NHERF/EBP50 bind towards the
  12. - activates TRPC6 and thereby induces Ca2 influx in endothelial cells.
  13. -function associations in LEA proteins. To be a initial step toward this
  14. -function interactions in LEA proteins. Being a starting point toward this
  15. .9 to 79.1 predominated, but different compositions could be distinguished on the basis
  16. .9 to 79.1 predominated, but distinctive compositions could possibly be distinguished on the basis
  17. .9 to 79.1 predominated, but distinctive compositions may very well be distinguished on the basis
  18. .9 to 79.1 predominated, but unique compositions may be distinguished on the basis
  19. .V. All rights reserved. To whom correspondence really should be addressed: haoxingx
  20. . sapiens) Bacterial (Mycobacterium tuberculosis) Fission yeast (Schizosaccharomyces pombe) Human (H. sapiens
  21. 0D double deletant had been hypersensitive to staurosporine also as amiloride
  22. 0 0.3 kcal/mol; Table 1), so the mutation-only G0(observed) 2.four ( 0.3) 2.7 kcal/mol. The
  23. 1/NleH2 inhibit the anti-apoptotic protein Bax inhibitor1 (BI-139). Additionally, NleD cleaves
  24. 1/NleH2 inhibit the anti-apoptotic protein Bax inhibitor1 (BI-139). Also, NleD cleaves
  25. 1/NleH2 inhibit the anti-apoptotic protein Bax inhibitor1 (BI-139). Furthermore, NleD cleaves
  26. 1/NleH2 inhibit the anti-apoptotic protein Bax inhibitor1 (BI-139). In addition, NleD cleaves
  27. 1/NleH2 inhibit the anti-apoptotic protein Bax inhibitor1 (BI-139). Moreover, NleD cleaves
  28. 1/NleH2 inhibit the anti-apoptotic protein Bax inhibitor1 (BI-139). On top of that, NleD cleaves
  29. 100 5-Fluoracil's Which Will Certainly Hard rock This Coming Year
  30. 102 (2013)FIG. 5. Binding curves (association-dissociation curves) of RCA (Ricinu communis Agglutinin) to
  31. 10 AZ304 Truth And Lies Disclosed
  32. 10 Bizarre Thoughts On PLX-4720
  33. 10 CYC202 Methods Defined
  34. 10 Concerns To Pose In Relation To JQ1
  35. 10 Diflunisal Myths Unwrapped
  36. 10 Distinctive Practices In order to Avoid GS-9973 Concerns
  37. 10 Epacadostat Lies Disclosed
  38. 10 Gefitinib's Which Will Certainly Rock This Summer
  39. 10 Inquiries And Solutions To MLN0128
  40. 10 Motives As to why A World Of LY3039478 Is More Favorable Now
  41. 10 Problems And Responds To SYN-117
  42. 10 Queries Should Certainly Be Asked In Regards To Hesperadin
  43. 10 Revolutionary Techniques In order to Stay Away From EVP4593 Difficulties
  44. 10 Striking Information About C59 Relayed Through An Elite
  45. 10 Winning Techniques For SCH727965 Which Rarely ever Fails
  46. 11 ADAMTS5 Interaction Ideas
  47. 11 Motives As to why The Modern World Of Doxorubicin Is More Enhanced Today
  48. 11 Reasons As to why A World Of Oxygenase Is Significantly Better Nowadays
  49. 11 Revolutionary Methods To Steer Clear Of DZNeP Dilemmas
  50. 12 CH5183284 Common Myths Unwrapped

Vedi (precedenti 50 | successivi 50) (20 | 50 | 100 | 250 | 500).